Anders Juul

Anders Juul

Clinical Professor

Member of:

  • Paediatrics

ORCID: 0000-0002-0534-4350

Publication year:
All
1 - 6 out of 6Page size: 10
  1. 1999
  2. Published

    Cirkulerende insulin-ligende vækstfaktor-I (IGF-I) og IGF bindingsproteiner: Normal regulation og klinisk anvendelse

    Juul, Anders, 1999, In: Pediatric Endocrinology Reviews. 13, p. 16-42 26 p.

    Research output: Contribution to journal › Review › Research

  3. Published

    Diagnosis of GH deficiency and use of GH in children with growth disorders. A report from the Drugs and Therapeutics Committee of European Society for paediatric Endocrinology

    Juul, Anders, Bernasconi, S., Chatelain, P., Hindsmarsh, P., Hochberg, Z., Hokke-Koelega, A., De Muinck Keizer-Schrama, S., Kiess, W., Oberfield, S., Strasburger, C., Volta, C., Westphal, O. & Skakkebæk, Niels Erik, 1999, In: Hormone Research. 51, p. 284-299 15 p.

    Research output: Contribution to journal › Review › Research

  4. Published

    Impact of growth hormone administration on other hormonal axes.

    Jørgensen, J., Ovesen, P., Juul, Anders, Hansen, T., Skakkebæk, Niels Erik & Christiansen, J., 1999, In: Hormone Research. 51, p. 121-126 5 p.

    Research output: Contribution to journal › Review › Research

  5. Published

    Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation

    Yu, H., Mistry, J., Nicar, M. J., Khosravi, M. J., Diamandis, A., van Doorn, J. & Juul, Anders, 1999, In: Journal of Clinical Laboratory Analysis. 13, 4, p. 166-72 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Vækst og Regeration

    Juul, Anders, Korndrup, J. & Skakkebæk, Niels Erik, 1999, Medicinsk Kompendium. 15 ed. p. 140-148 8 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research

  7. Published

    determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered?

    Juul, Anders, 1999, In: Hormone Research. 51, p. 141-148 7 p.

    Research output: Contribution to journal › Review › Research

ID: 546941